Top ▲
Target not currently curated in GtoImmuPdb
Target id: 2164
Nomenclature: phosphatidylinositol-4-phosphate 5-kinase type 1 alpha
Abbreviated Name: PIP5K1A
Family: Type I PIP kinases (1-phosphatidylinositol-4-phosphate 5-kinase family), Phosphatidylinositol phosphate kinases
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 562 | 1q21.3 | PIP5K1A | phosphatidylinositol-4-phosphate 5-kinase type 1 alpha | 4,7 |
Mouse | - | 546 | 3 F2.1 | Pip5k1a | phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha | |
Rat | - | 546 | 2 q34 | Pip5k1a | phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha |
Database Links | |
Alphafold | Q99755 (Hs), P70182 (Mm) |
BRENDA | 2.7.1.68 |
CATH/Gene3D | 3.30.800.10, 3.30.810.10 |
ChEMBL Target | CHEMBL5969 (Hs) |
Ensembl Gene | ENSG00000143398 (Hs), ENSMUSG00000028126 (Mm), ENSRNOG00000021068 (Rn) |
Entrez Gene | 8394 (Hs), 18720 (Mm), 365865 (Rn) |
Human Protein Atlas | ENSG00000143398 (Hs) |
KEGG Enzyme | 2.7.1.68 |
KEGG Gene | hsa:8394 (Hs), mmu:18720 (Mm), rno:365865 (Rn) |
OMIM | 603275 (Hs) |
Pharos | Q99755 (Hs) |
RefSeq Nucleotide | NM_003557 (Hs), NM_008847 (Mm), NM_001042621 (Rn) |
RefSeq Protein | NP_003548 (Hs), NP_032873 (Mm), NP_001036086 (Rn) |
UniProtKB | Q99755 (Hs), P70182 (Mm) |
Wikipedia | PIP5K1A (Hs) |
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
DiscoveRx KINOMEscan® screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 2,6 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: PIP5K1A | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
Physiological Functions | ||||||||
|
||||||||
|
||||||||
|
Physiological Consequences of Altering Gene Expression | ||||||||||
|
1. Chao WT, Daquinag AC, Ashcroft F, Kunz J. (2010) Type I PIPK-alpha regulates directed cell migration by modulating Rac1 plasma membrane targeting and activation. J Cell Biol, 190 (2): 247-62. [PMID:20660631]
2. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
3. Hasegawa H, Noguchi J, Yamashita M, Okada R, Sugimoto R, Furuya M, Unoki T, Funakoshi Y, Baba T, Kanaho Y. (2012) Phosphatidylinositol 4-phosphate 5-kinase is indispensable for mouse spermatogenesis. Biol Reprod, 86 (5): 136, 1-12. [PMID:22321832]
4. Loijens JC, Anderson RA. (1996) Type I phosphatidylinositol-4-phosphate 5-kinases are distinct members of this novel lipid kinase family. J Biol Chem, 271 (51): 32937-43. [PMID:8955136]
5. Semenas J, Hedblom A, Miftakhova RR, Sarwar M, Larsson R, Shcherbina L, Johansson ME, Härkönen P, Sterner O, Persson JL. (2014) The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer. Proc Natl Acad Sci USA, 111 (35): E3689-98. [PMID:25071204]
6. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
7. Xie Y, Zhu L, Zhao G. (2000) Assignment of type I phosphatidylinositol-4-phosphate 5-kinase (PIP5K1A) to human chromosome bands 1q22--> q24 by in situ hybridization. Cytogenet Cell Genet, 88 (3-4): 197-9. [PMID:10828584]
Phosphatidylinositol phosphate kinases: phosphatidylinositol-4-phosphate 5-kinase type 1 alpha. Last modified on 19/08/2015. Accessed on 04/12/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetoimmunopharmacology.org/GRAC/ObjectDisplayForward?objectId=2164.